![Myeloma Paper of the Day, February 10th, suggested by Robert Orlowski](https://oncodaily.com/pub/uploads/2025/02/IMG_8187-1280x720.jpg)
Feb 10, 2025, 14:12
Myeloma Paper of the Day, February 10th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Systematic review and meta-analysis of outcomes in solitary plasmacytomas finds patients with up to 10% BMPCs had reduced disease-free survival (15.7 vs. 79 mos); risks for shorter DFS included clonal marrow PCs and dFLC > 5 mg/dl.”
Authors: Charalampos Charalampous et al.
![Myeloma Paper of the Day, February 10th, suggested by Robert Orlowski 1 Myeloma Paper of the Day, February 10th, suggested by Robert Orlowski](https://oncodaily.com/pub/uploads/2025/02/Screenshot-2025-02-10-190744-800x378.png)
More posts featuring Robert Orlowski.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 10, 2025, 14:12
Feb 10, 2025, 11:18
Feb 10, 2025, 10:52
Feb 10, 2025, 10:45